Alnylam Pharmaceuticals Inc. (ALNY) declined -5.73% or -4.16 to $68.38. It is near to 854217 shares traded, which is 90.98% compare to the average total volume 938895. The market cap of ALNY is $6.91 billion. The year to date change is -53.87%. The 52 week price range is from $63.57 to $153.99. Price of ALNY have changed -8.75% during last week. It have changed 1.48% over last month, -23.50% over last 3 months, -30.66% over last 6 months and -40.95% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ALNY is 77.65. It is 13.56% above current price. The 200-day Moving Averages for ALNY is 97.64. It is 42.79% above current price. The 52-week High is 153.99. It is 125.20% from the current price. The 52-week Low is 63.57. It is -7.03% from current price.
There are some statistics of ALNY. It is has market cap $6.91 billion. The share outstanding is 101.03 million. The average volume is 938895. The revenue is 37.92M. The percent of top 15 Institution holding is 140.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ALNY is -54.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ALNY is -45.64%.